首页 > 最新文献

Revista Espanola De Medicina Nuclear E Imagen Molecular最新文献

英文 中文
El efecto sinérgico de la resonancia magnética multiparamétrica y la imagen PET/TC con [18F]PSMA-1007 en el estudio de la recidiva del adenocarcinoma prostático localmente avanzado 多参数磁共振成像和PET/ CT成像与[18F]PSMA-1007在局部晚期前列腺腺癌复发研究中的协同作用
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-05-16 DOI: 10.1016/j.remn.2025.500104
D. Schmitt , L. Schimmöller , E. Novruzov , J. Kirchner , M. Boschheidgen , E. Mamlins , C. Antke , Y. Mori , G. Antoch , F.L. Giesel
{"title":"El efecto sinérgico de la resonancia magnética multiparamétrica y la imagen PET/TC con [18F]PSMA-1007 en el estudio de la recidiva del adenocarcinoma prostático localmente avanzado","authors":"D. Schmitt , L. Schimmöller , E. Novruzov , J. Kirchner , M. Boschheidgen , E. Mamlins , C. Antke , Y. Mori , G. Antoch , F.L. Giesel","doi":"10.1016/j.remn.2025.500104","DOIUrl":"10.1016/j.remn.2025.500104","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500104"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Actualización del procedimiento y guía de interpretación del estudio PET cerebral con 18F-FDG 使用18F-FDG进行脑PET研究的程序更新和解释指南
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-05-27 DOI: 10.1016/j.remn.2025.500159
C. Vigil Díaz , P. Paredes Rodríguez , A. Perissinotti , E. Fernando Guillén , D.A. López Mora , J.A. Lojo Ramírez , P. Aguiar Fernández , V. Camacho Martí , M. Nieves Cabrera-Martín , por el grupo de Trabajo de Neuroimagen de la SEMNIM
The increase in the prevalence of dementia in our clinical setting poses a diagnostic challenge for the Nuclear Medicine specialist. The aim of this study is to review the modifications in the procedure and to describe the usefulness of the use of brain PET with 18F-FDG in different clinical indications, both classic and emerging ones. The SEMNIM Neuroimaging working group has considered appropriate to update the procedures available in Spanish, in order to optimize the quality of this technique and the interpretation of its findings, both for the specialist in Nuclear Medicine and the rest of the professionals involved in the diagnosis and treatment of neurodegenerative diseases.
痴呆患病率的增加在我们的临床设置提出了核医学专家的诊断挑战。本研究的目的是回顾该程序的修改,并描述18F-FDG在不同临床适应症(包括经典和新出现的适应症)中使用脑PET的有用性。SEMNIM神经成像工作组认为有必要更新现有的西班牙语程序,以便为核医学专家和参与诊断和治疗神经退行性疾病的其他专业人员优化这项技术的质量和对其结果的解释。
{"title":"Actualización del procedimiento y guía de interpretación del estudio PET cerebral con 18F-FDG","authors":"C. Vigil Díaz ,&nbsp;P. Paredes Rodríguez ,&nbsp;A. Perissinotti ,&nbsp;E. Fernando Guillén ,&nbsp;D.A. López Mora ,&nbsp;J.A. Lojo Ramírez ,&nbsp;P. Aguiar Fernández ,&nbsp;V. Camacho Martí ,&nbsp;M. Nieves Cabrera-Martín ,&nbsp;por el grupo de Trabajo de Neuroimagen de la SEMNIM","doi":"10.1016/j.remn.2025.500159","DOIUrl":"10.1016/j.remn.2025.500159","url":null,"abstract":"<div><div>The increase in the prevalence of dementia in our clinical setting poses a diagnostic challenge for the Nuclear Medicine specialist. The aim of this study is to review the modifications in the procedure and to describe the usefulness of the use of brain PET with <sup>18</sup>F-FDG in different clinical indications, both classic and emerging ones. The SEMNIM Neuroimaging working group has considered appropriate to update the procedures available in Spanish, in order to optimize the quality of this technique and the interpretation of its findings, both for the specialist in Nuclear Medicine and the rest of the professionals involved in the diagnosis and treatment of neurodegenerative diseases.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500159"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144563895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Justificación e impacto del uso de la SPECT 123I-FP-CIT en el diagnóstico diferencial y manejo de los trastornos del movimiento (TM) en un hospital de referencia nacional 在国家转诊医院使用SPECT 123I-FP-CIT进行运动障碍的鉴别诊断和管理的理由和影响
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-01-06 DOI: 10.1016/j.remn.2024.500092
L. Canales Rodríguez , M. Mitjavila Casanovas , S. Ruiz Solís

Introduction

Cerebral single photon emission computed tomography (SPECT) using 123I-FP-CIT is a key tool in the differential diagnosis of movement disorders (MD), but its appropriate indication is essential to optimize resources and avoid unnecessary tests.

Objective

To evaluate the adequacy and impact of SPECT 123I-FP-CIT in the diagnosis and management of MD according to clinical guidelines.

Methodology

Retrospective study involving 249 patients with suspected parkinsonism (PK) of uncertain origin. All underwent SPECT 123I-FP-CIT and had a clinical follow-up of exceeding 12 months. Requests were classified based on their adherence to clinical guidelines. Variables analyzed included sex, age, justification for the request, management after SPECT, and final diagnosis.

Results

91.57% of the requests were appropriate, while 8.43% did not adhere to the guidelines. Diagnosis changed in 48.6% of cases and management in 70.68% after the scan, especially in inconclusive cases and initiation of therapy. General neurologists evaluated more cases and made more appropriate requests (96,3% vs 76,67%;p < 0,001). However, MD specialists, despite less appropriate use of the text, achieved a higher number of conclusive diagnoses in complex cases.

Conclusion

SPECT 123I-FP-CIT has significant clinical impact when used in accordance with clinical guidelines, improving the diagnosis and management of MD. Unjustified scans reduce its utility. Collaboration between general neurologists and MD specialists is fundamental; the latter, although showing less adherence to guidelines in requesting the test, achieve a higher number of conclusive diagnoses in complex cases.
使用123I-FP-CIT的大脑单光子发射计算机断层扫描(SPECT)是运动障碍(MD)鉴别诊断的关键工具,但其适当的适应症对于优化资源和避免不必要的检查至关重要。目的根据临床指南评价SPECT 123I-FP-CIT在MD诊断和治疗中的充分性和影响。方法回顾性研究249例来源不明的疑似帕金森病患者。所有患者均接受SPECT 123I-FP-CIT检查,临床随访超过12个月。根据对临床指南的遵守程度对请求进行分类。分析的变量包括性别、年龄、请求的理由、SPECT后的处理和最终诊断。结果91.57%的请求是合适的,8.43%的请求没有遵守指南。扫描后诊断改变48.6%,治疗改变70.68%,特别是在不确定病例和开始治疗时。普通神经科医生评估的病例更多,提出的要求也更恰当(96.3% vs 76.67%;p <;0001)。然而,医学专家,尽管不太适当地使用文本,在复杂病例中取得了更高数量的结论性诊断。结论按照临床指南使用spect 123I-FP-CIT具有显著的临床效果,提高了MD的诊断和管理,不合理的扫描降低了其应用价值。全科神经科医生和医学专家之间的合作至关重要;后者虽然在要求检测时较少遵守指南,但在复杂病例中获得更多的结论性诊断。
{"title":"Justificación e impacto del uso de la SPECT 123I-FP-CIT en el diagnóstico diferencial y manejo de los trastornos del movimiento (TM) en un hospital de referencia nacional","authors":"L. Canales Rodríguez ,&nbsp;M. Mitjavila Casanovas ,&nbsp;S. Ruiz Solís","doi":"10.1016/j.remn.2024.500092","DOIUrl":"10.1016/j.remn.2024.500092","url":null,"abstract":"<div><h3>Introduction</h3><div>Cerebral single photon emission computed tomography (SPECT) using <sup>123</sup>I-FP-CIT is a key tool in the differential diagnosis of movement disorders (MD), but its appropriate indication is essential to optimize resources and avoid unnecessary tests.</div></div><div><h3>Objective</h3><div>To evaluate the adequacy and impact of SPECT <sup>123</sup>I-FP-CIT in the diagnosis and management of MD according to clinical guidelines.</div></div><div><h3>Methodology</h3><div>Retrospective study involving 249 patients with suspected parkinsonism (PK) of uncertain origin. All underwent SPECT <sup>123</sup>I-FP-CIT and had a clinical follow-up of exceeding 12 months. Requests were classified based on their adherence to clinical guidelines. Variables analyzed included sex, age, justification for the request, management after SPECT, and final diagnosis.</div></div><div><h3>Results</h3><div>91.57% of the requests were appropriate, while 8.43% did not adhere to the guidelines. Diagnosis changed in 48.6% of cases and management in 70.68% after the scan, especially in inconclusive cases and initiation of therapy. General neurologists evaluated more cases and made more appropriate requests (96,3% vs 76,67%;p<!--> <!-->&lt;<!--> <!-->0,001). However, MD specialists, despite less appropriate use of the text, achieved a higher number of conclusive diagnoses in complex cases.</div></div><div><h3>Conclusion</h3><div>SPECT <sup>123</sup>I-FP-CIT has significant clinical impact when used in accordance with clinical guidelines, improving the diagnosis and management of MD. Unjustified scans reduce its utility. Collaboration between general neurologists and MD specialists is fundamental; the latter, although showing less adherence to guidelines in requesting the test, achieve a higher number of conclusive diagnoses in complex cases.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500092"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Una comida sólida hipoalergénica para la gammagrafía de vaciado gástrico basada en la dieta mediterránea. «Una dieta para vaciarlos a todos» 一种基于地中海饮食的低致敏固体食物,用于胃排空伽玛图。《清空所有人的饮食》
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-04-16 DOI: 10.1016/j.remn.2024.500093
P. Zaragoza-Ballester , P. Sarandeses Fernández , I. González Martín , C. Martin-Arriscado Arroba , M.I. Cabanillas Pérez , X. Guarnizo Poma , I. Castel de Lucas , A. Galiana Morón , D. Vega Pérez , A.I. Romero Reina , M.J. Tabuenca Mateo , S. Ruiz Solís

Aim

We aim to establish normal values and standardize a hypoallergenic and Mediterranean diet for gastric emptying scintigraphy (GES).

Material and methods

In a prospective cohort of healthy volunteers, we performed GES of a [99Tc]TcDTPA2 labelled hypoallergenic meal (egg, potato, rice and olive oil). Anterior and posterior images were simultaneously acquired at 0, 30, 60, 110, 120, 130, 180, 230, 240 and 250 minutes. Cross-sectional analysis was performed between demographic data and gastric retention values. A score covariance analysis model was used to observer changes between measurements over time.

Results

50 participants (29 women) were included. Mean values and standard deviation (5-95th) for gastric retention percentages at 60, 120, 180, 240 minutes were 51.40 ± 8.63 (36.5-66.1), 21.66 ± 9.40 (6.5-38.2), 7.58 ± 5.77 (1.5-19.1) and 2.94 ± 2.08 (1-7.3), respectively. Male participants had a significative faster gastric emptying compared to women in practically all the acquisitions. Male participants and smoker participants generated a significative decrease of gastric retention values in generalized linear model (male coefficient −4.818, 95% CI: −7.24 to −2.39, P < .001; and smoker coefficient of −3.484, 95% CI: −6.29 to −0.67, P < .05).

Conclusion

This study standardizes and establishes normal values for GES with the first hypoallergenic solid meal based on consensus recommendations and a Mediterranean diet; suitable for most patients with allergic or sensitive-conditions to other meal components.
目的:建立低过敏性地中海饮食对胃排空造影(GES)的正常值和标准化。材料和方法在健康志愿者的前瞻性队列中,我们对[99Tc]TcDTPA2 -标记的低过敏性膳食(鸡蛋、土豆、大米和橄榄油)进行了GES。在0、30、60、110、120、130、180、230、240、250分钟同时获取前后位图像。在人口统计学数据和胃潴留值之间进行横断面分析。采用分数协方差分析模型观察各测量值随时间的变化。结果共纳入50例受试者,其中女性29例。60、120、180、240 min胃潴留率的平均值为51.40±8.63(36.5-66.1),标准差为21.66±9.40(6.5-38.2),7.58±5.77(1.5-19.1),2.94±2.08(1-7.3),标准差为5-95。在几乎所有的收购中,男性参与者的胃排空速度都明显快于女性。在广义线性模型中,男性参与者和吸烟者的胃潴留值显著降低(男性系数- 4.818,95% CI: - 7.24至- 2.39,P <;措施;吸烟者系数为- 3.484,95% CI: - 6.29 ~ - 0.67, P <;. 05)。结论:本研究基于共识建议和地中海饮食,以低过敏性固体餐为标准,建立了GES的正常值;适用于大多数对其他膳食成分过敏或敏感的患者。
{"title":"Una comida sólida hipoalergénica para la gammagrafía de vaciado gástrico basada en la dieta mediterránea. «Una dieta para vaciarlos a todos»","authors":"P. Zaragoza-Ballester ,&nbsp;P. Sarandeses Fernández ,&nbsp;I. González Martín ,&nbsp;C. Martin-Arriscado Arroba ,&nbsp;M.I. Cabanillas Pérez ,&nbsp;X. Guarnizo Poma ,&nbsp;I. Castel de Lucas ,&nbsp;A. Galiana Morón ,&nbsp;D. Vega Pérez ,&nbsp;A.I. Romero Reina ,&nbsp;M.J. Tabuenca Mateo ,&nbsp;S. Ruiz Solís","doi":"10.1016/j.remn.2024.500093","DOIUrl":"10.1016/j.remn.2024.500093","url":null,"abstract":"<div><h3>Aim</h3><div>We aim to establish normal values and standardize a hypoallergenic and Mediterranean diet for gastric emptying scintigraphy (GES).</div></div><div><h3>Material and methods</h3><div>In a prospective cohort of healthy volunteers, we performed GES of a [<sup>99</sup>Tc]TcDTPA<sup>2</sup><sup>−</sup> labelled hypoallergenic meal (egg, potato, rice and olive oil). Anterior and posterior images were simultaneously acquired at 0, 30, 60, 110, 120, 130, 180, 230, 240 and 250<!--> <!-->minutes. Cross-sectional analysis was performed between demographic data and gastric retention values. A score covariance analysis model was used to observer changes between measurements over time.</div></div><div><h3>Results</h3><div>50 participants (29 women) were included. Mean values and standard deviation (5-95th) for gastric retention percentages at 60, 120, 180, 240<!--> <!-->minutes were 51.40<!--> <!-->±<!--> <!-->8.63 (36.5-66.1), 21.66<!--> <!-->±<!--> <!-->9.40 (6.5-38.2), 7.58<!--> <!-->±<!--> <!-->5.77 (1.5-19.1) and 2.94<!--> <!-->±<!--> <!-->2.08 (1-7.3), respectively. Male participants had a significative faster gastric emptying compared to women in practically all the acquisitions. Male participants and smoker participants generated a significative decrease of gastric retention values in generalized linear model (male coefficient −4.818, 95%<!--> <!-->CI: −7.24 to −2.39, <em>P</em> <!-->&lt;<!--> <!-->.001; and smoker coefficient of −3.484, 95%<!--> <!-->CI: −6.29 to −0.67, <em>P</em> <!-->&lt;<!--> <!-->.05).</div></div><div><h3>Conclusion</h3><div>This study standardizes and establishes normal values for GES with the first hypoallergenic solid meal based on consensus recommendations and a Mediterranean diet; suitable for most patients with allergic or sensitive-conditions to other meal components.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500093"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relación entre el estado de HER2 adquirido a partir de los datos patológicos y los parámetros metabólicos obtenidos mediante [18F]FDG PET/TC pretratamiento en adenocarcinomas gástricos 通过[18F]FDG PET/TC预处理胃腺癌的病理数据获得的HER2状态与代谢参数之间的关系
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-06-24 DOI: 10.1016/j.remn.2024.500080
M.N. Acar Tayyar , M.Ö. Tamam , G.B. Babacan , M.C. Şahin , H. Özçevik , S. Şengiz Erhan , A.E. Öztürk

Objective

Overexpression of Human Epidermal Growth Factor Receptor 2 (HER2) is thought to be more aggressive in gastric cancer. This study aimed to evaluate the predictability of HER2 status and other prognostic pathologic parameters using [18F]FDG PET/CT and to investigate its impact on survival.

Methods

Pretreatment metabolic parameters measured by [18F]FDG PET/CT as a prognostic factor were retrospectively evaluated in 117 HER2-analysed patients. The relationship between pathological data, tumor metabolic characteristics, and distant metastases was examined, and the effect on survival was investigated.

Results

Among the 117 patients, 17.1% were HER2-positive (HER2+), and 82.9% were HER2-negative (HER2). There was no significant association between PET/CT parameters in the HER2+ and HER2 patient groups. HER2+ patients had higher 1- and 3-year survival expectations than HER2 patients (80-37.9%; 47.5-20%; respectively). There was no statistically significant difference in overall survival. In Cox-regression analysis, while the presence of vascular invasion, local invasion, and distant metastasis were poor prognostic factors, HER2 was not a prognostic factor. Vascular invasion and local invasion (T3/T4) were also associated with higher SUVmax values. Patients with distant metastases had significantly higher SUVmax, SUVmean, and TLG.

Conclusion

This study showed no association between HER2 expression and [18F]FDG PET/CT metabolic parameters. However, regardless of HER2 status, the results indicated distant metastasis, local invasion, and vascular invasion could be associated with primary tumor metabolism. PET/CT parameters predict tumor aggressiveness and disease prognosis better than HER2 status.
目的人表皮生长因子受体2 (HER2)过表达被认为在胃癌中更具侵袭性。本研究旨在利用[18F]FDG PET/CT评估HER2状态和其他预后病理参数的可预测性,并探讨其对生存的影响。方法回顾性评估117例her2分析患者的治疗前代谢参数[18F]FDG PET/CT作为预后因素。检查病理资料、肿瘤代谢特征与远处转移的关系,并探讨对生存的影响。结果117例患者中,HER2阳性(HER2+)占17.1%,HER2阴性(HER2−)占82.9%。HER2+和HER2 -患者组PET/CT参数之间无显著相关性。HER2+患者的1年和3年生存率预期高于HER2 -患者(80-37.9%;47.5 - -20%;分别)。两组总生存率无统计学差异。cox -回归分析中,血管浸润、局部浸润和远处转移是不良预后因素,HER2不是预后因素。血管侵犯和局部侵犯(T3/T4)也与较高的SUVmax值相关。远处转移患者的SUVmax、SUVmean和TLG显著升高。结论本研究显示HER2表达与[18F]FDG PET/CT代谢参数无相关性。然而,无论HER2状态如何,结果表明远处转移、局部侵袭和血管侵袭可能与原发性肿瘤代谢有关。PET/CT参数预测肿瘤侵袭性和疾病预后优于HER2状态。
{"title":"Relación entre el estado de HER2 adquirido a partir de los datos patológicos y los parámetros metabólicos obtenidos mediante [18F]FDG PET/TC pretratamiento en adenocarcinomas gástricos","authors":"M.N. Acar Tayyar ,&nbsp;M.Ö. Tamam ,&nbsp;G.B. Babacan ,&nbsp;M.C. Şahin ,&nbsp;H. Özçevik ,&nbsp;S. Şengiz Erhan ,&nbsp;A.E. Öztürk","doi":"10.1016/j.remn.2024.500080","DOIUrl":"10.1016/j.remn.2024.500080","url":null,"abstract":"<div><h3>Objective</h3><div>Overexpression of Human Epidermal Growth Factor Receptor 2 (HER2) is thought to be more aggressive in gastric cancer. This study aimed to evaluate the predictability of HER2 status and other prognostic pathologic parameters using [<sup>18</sup>F]FDG PET/CT and to investigate its impact on survival.</div></div><div><h3>Methods</h3><div>Pretreatment metabolic parameters measured by [<sup>18</sup>F]FDG PET/CT as a prognostic factor were retrospectively evaluated in 117 HER2-analysed patients. The relationship between pathological data, tumor metabolic characteristics, and distant metastases was examined, and the effect on survival was investigated.</div></div><div><h3>Results</h3><div>Among the 117 patients, 17.1% were HER2-positive (HER2<sup>+</sup>), and 82.9% were HER2-negative (HER2<sup>−</sup>). There was no significant association between PET/CT parameters in the HER2<sup>+</sup> and HER2<sup>−</sup> patient groups. HER2<sup>+</sup> patients had higher 1- and 3-year survival expectations than HER2<sup>−</sup> patients (80-37.9%; 47.5-20%; respectively). There was no statistically significant difference in overall survival. In Cox-regression analysis, while the presence of vascular invasion, local invasion, and distant metastasis were poor prognostic factors, HER2 was not a prognostic factor. Vascular invasion and local invasion (T3/T4) were also associated with higher SUVmax values. Patients with distant metastases had significantly higher SUVmax, SUVmean, and TLG.</div></div><div><h3>Conclusion</h3><div>This study showed no association between HER2 expression and [<sup>18</sup>F]FDG PET/CT metabolic parameters. However, regardless of HER2 status, the results indicated distant metastasis, local invasion, and vascular invasion could be associated with primary tumor metabolism. PET/CT parameters predict tumor aggressiveness and disease prognosis better than HER2 status.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500080"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear: Parte III 核医学中新型放射性核素的现状和未来前景:第三部分
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-05-05 DOI: 10.1016/j.remn.2025.500161
I. Torres , R. Ramos , M.L. Domínguez , J.J. Rosales , A. Roteta , E. Prieto , L. Sancho , M. de Arcocha , G. Quincoces , en nombre del Grupo de Oncología de la SEMNIM
In this third installment of the continuing education series, the clinical and therapeutic applications of zirconium, astatine and thorium are analyzed in depth. Although they are not described as theragnostic pairs, each of these radionuclides plays a fundamental role in precision medicine, which is rapidly advancing within Nuclear Medicine.
We begin by analyzing zirconium-89, a positron emitter whose long half-life makes it particularly suitable for labeling large molecules with slow kinetics, such as antibodies, playing a crucial role in immunotherapy. The use of astatine-211, an alpha-emitting radionuclide with a simple decay scheme and chemical behavior similar to iodine, is also discussed. Its main challenge lies in its production, as it requires cyclotrons capable of generating highly energetic alpha particle beams. Furthermore, thorium-227, a 100% alpha emitter, is reviewed. This radionuclide exhibits excellent chelation properties, enabling its conjugation with tumor-targeting molecules to produce thorium-labeled conjugates. While this technique is yielding promising preclinical results, the use of thorium faces challenges, including the potential separation of radium-223 from the molecule and the dependence of activity measurements on the time of production. Since it takes 100 days to reach equilibrium, activity assessment is based on photons emitted by its daughter radionuclides.
Despite these challenges, these radionuclides are driving the evolution of precision medicine, expanding therapeutic and diagnostic possibilities within Nuclear Medicine.
Nuclear Medicine.
在继续教育系列的第三部分中,深入分析了锆、砹和钍的临床和治疗应用。虽然它们没有被描述为诊断对,但这些放射性核素中的每一种都在精确医学中发挥着重要作用,这在核医学中正在迅速发展。我们首先分析锆-89,它是一种正电子发射器,半衰期长,特别适合标记动力学慢的大分子,如抗体,在免疫治疗中起着至关重要的作用。还讨论了砹-211的使用,它是一种具有简单的衰变机制和类似于碘的化学行为的α -发射放射性核素。它的主要挑战在于它的生产,因为它需要能够产生高能粒子束的回旋加速器。此外,还对100% α发射体钍-227进行了评述。这种放射性核素表现出优异的螯合特性,使其与肿瘤靶向分子结合,产生钍标记的偶联物。虽然这项技术正在产生有希望的临床前结果,但钍的使用面临着挑战,包括从分子中分离镭-223的可能性以及活性测量对生产时间的依赖。由于达到平衡需要100天,因此活动评估是基于其子放射性核素发射的光子。尽管存在这些挑战,但这些放射性核素正在推动精准医学的发展,扩大核医学的治疗和诊断可能性。核医学。
{"title":"Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear: Parte III","authors":"I. Torres ,&nbsp;R. Ramos ,&nbsp;M.L. Domínguez ,&nbsp;J.J. Rosales ,&nbsp;A. Roteta ,&nbsp;E. Prieto ,&nbsp;L. Sancho ,&nbsp;M. de Arcocha ,&nbsp;G. Quincoces ,&nbsp;en nombre del Grupo de Oncología de la SEMNIM","doi":"10.1016/j.remn.2025.500161","DOIUrl":"10.1016/j.remn.2025.500161","url":null,"abstract":"<div><div>In this third installment of the continuing education series, the clinical and therapeutic applications of zirconium, astatine and thorium are analyzed in depth. Although they are not described as theragnostic pairs, each of these radionuclides plays a fundamental role in precision medicine, which is rapidly advancing within Nuclear Medicine.</div><div>We begin by analyzing zirconium-89, a positron emitter whose long half-life makes it particularly suitable for labeling large molecules with slow kinetics, such as antibodies, playing a crucial role in immunotherapy. The use of astatine-211, an alpha-emitting radionuclide with a simple decay scheme and chemical behavior similar to iodine, is also discussed. Its main challenge lies in its production, as it requires cyclotrons capable of generating highly energetic alpha particle beams. Furthermore, thorium-227, a 100% alpha emitter, is reviewed. This radionuclide exhibits excellent chelation properties, enabling its conjugation with tumor-targeting molecules to produce thorium-labeled conjugates. While this technique is yielding promising preclinical results, the use of thorium faces challenges, including the potential separation of radium-223 from the molecule and the dependence of activity measurements on the time of production. Since it takes 100 days to reach equilibrium, activity assessment is based on photons emitted by its daughter radionuclides.</div><div>Despite these challenges, these radionuclides are driving the evolution of precision medicine, expanding therapeutic and diagnostic possibilities within Nuclear Medicine.</div><div>Nuclear Medicine.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500161"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Redefiniendo la localización preoperatoria basada en imágenes de los adenomas en pacientes con hiperparatiroidismo primario candidatos a cirugía mínimamente invasiva 重新定义原发性甲状旁腺瘤患者术前成像位置,以微创手术为目标
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-04-22 DOI: 10.1016/j.remn.2024.500091
S. Casanueva-Eliceiry , M. Manyalich-Blasi , A. Farré-Melero , A. Niñerola-Baizán , D. Saavedra , M. Mora-Porta , F.A. Hanzu , A. Orois , M. Squarcia , M. Rodrigo-Calvo , M. Tormo-Ratera , K. Quintero-Martinez , D. Fuster-Pelfort , O. Vidal-Pérez , S. Vidal-Sicart

Background and objectives

To compare the diagnostic accuracy of [18F]-Fluorocholine (FCH) PET/CT with conventional [99mTc]Tc-MIBI scintigraphy and cervical ultrasound (USG) for the preoperative localization of hyperfunctioning parathyroid tissue (HFPT) in patients with primary hyperparathyroidism (PHPT).

Materials and methods

This prospective study included 90 patients diagnosed with PHPT who underwent [18F]F-CH PET/CT, [99mTc]Tc-MIBI SPECT/CT and Neck USG. The diagnostic accuracy of each imaging modality was assessed using intraoperative findings and histopathological confirmation as the gold standard. The localization accuracy was evaluated based on specific quadrant detection, laterality, and ectopic gland identification. The study also explored the correlation between imaging findings and biochemical parameters, including preoperative and postoperative PTH and calcium levels.

Results

[18F]F-CH PET/CT demonstrated superior accuracy in detecting pathological parathyroid glandscompared to [99mTc]Tc-MIBI SPECT/CT and USG. [18F]F-CH PET/CT correctly identified 98.9% of patientswith pathological glands, with a specific location accuracy of 93.2%, 65.9% and 38.8% for [18F]F-CH PET/CT,[99mTc]Tc-MIBI SPECT/CT and USG, respectively.
For ectopic adenomas, FCH PET/CT achieved an accuracy of 100% (4/4), while MIBI and neck ultrasound identified these in 50% (2/4) and 0% (0/4) of cases, respectively.
There were two cases of multiglandular disease, [18F]F-CH PET/CT and [99mTc]Tc-MIBI each detected one gland in one case (50%) while USG detected none; in the other case, [18F]F-CH PET/CT and USG identified both glands (100%), and [99mTc]Tc-MIBI detected none.
Significant correlations were observed between SUVmax values from [18F]F-CH PET/CT and gland size, weight, and preoperative PTH levels.

Conclusions

[18F]F-CH PET/CT outperformed conventional imaging modalities in the preoperative localization of HFPT, particularly in challenging cases such ectopic or multiglandular disease. These findings support its potential as an effective and reliable imaging tool for the management of primary hyperparathyroidism.
背景与目的比较[18F]-氟胆碱(FCH) PET/CT与常规[99mTc]Tc-MIBI显像及宫颈超声(USG)对原发性甲状旁腺功能亢进(PHPT)患者术前定位甲状旁腺功能亢进(HFPT)的诊断准确性。材料和方法本前瞻性研究纳入90例诊断为PHPT的患者,分别行[18F]F-CH PET/CT、[99mTc]Tc-MIBI SPECT/CT和颈部USG检查。以术中发现和组织病理学证实为金标准评估每种成像方式的诊断准确性。定位精度是基于特定象限检测、侧边性和异位腺体识别来评估的。该研究还探讨了影像学表现与生化参数的相关性,包括术前和术后甲状旁腺激素和钙水平。结果[18F]与[99mTc]Tc-MIBI SPECT/CT和USG相比,F-CH PET/CT对病理性甲状旁腺的检测精度更高。[18F]F-CH PET/CT对病理腺体的正确率为98.9%,其中[18F]F-CH PET/CT、[99mTc]Tc-MIBI SPECT/CT和USG的特异定位正确率分别为93.2%、65.9%和38.8%。对于异位腺瘤,FCH PET/CT的准确率为100%(4/4),而MIBI和颈部超声的准确率分别为50%(2/4)和0%(0/4)。多腺病变2例,[18F]F-CH PET/CT和[99mTc]Tc-MIBI各1例(50%)检出1个腺体,USG未检出;在另一例中,[18F]F-CH PET/CT和USG检测到两个腺体(100%),[99mTc]Tc-MIBI未检测到腺体。[18F]F-CH PET/CT的SUVmax值与腺体大小、体重和术前PTH水平之间存在显著相关性。结论[18F]F-CH PET/CT在HFPT术前定位方面优于传统成像方式,特别是在异位或多腺疾病等具有挑战性的病例中。这些发现支持其作为治疗原发性甲状旁腺功能亢进的有效和可靠的成像工具的潜力。
{"title":"Redefiniendo la localización preoperatoria basada en imágenes de los adenomas en pacientes con hiperparatiroidismo primario candidatos a cirugía mínimamente invasiva","authors":"S. Casanueva-Eliceiry ,&nbsp;M. Manyalich-Blasi ,&nbsp;A. Farré-Melero ,&nbsp;A. Niñerola-Baizán ,&nbsp;D. Saavedra ,&nbsp;M. Mora-Porta ,&nbsp;F.A. Hanzu ,&nbsp;A. Orois ,&nbsp;M. Squarcia ,&nbsp;M. Rodrigo-Calvo ,&nbsp;M. Tormo-Ratera ,&nbsp;K. Quintero-Martinez ,&nbsp;D. Fuster-Pelfort ,&nbsp;O. Vidal-Pérez ,&nbsp;S. Vidal-Sicart","doi":"10.1016/j.remn.2024.500091","DOIUrl":"10.1016/j.remn.2024.500091","url":null,"abstract":"<div><h3>Background and objectives</h3><div>To compare the diagnostic accuracy of [<sup>18</sup>F]-Fluorocholine (FCH) PET/CT with conventional [<sup>99m</sup>Tc]Tc-MIBI scintigraphy and cervical ultrasound (USG) for the preoperative localization of hyperfunctioning parathyroid tissue (HFPT) in patients with primary hyperparathyroidism (PHPT).</div></div><div><h3>Materials and methods</h3><div>This prospective study included 90 patients diagnosed with PHPT who underwent [<sup>18</sup>F]F-CH PET/CT, [<sup>99m</sup>Tc]Tc-MIBI SPECT/CT and Neck USG. The diagnostic accuracy of each imaging modality was assessed using intraoperative findings and histopathological confirmation as the gold standard. The localization accuracy was evaluated based on specific quadrant detection, laterality, and ectopic gland identification. The study also explored the correlation between imaging findings and biochemical parameters, including preoperative and postoperative PTH and calcium levels.</div></div><div><h3>Results</h3><div>[<sup>18</sup>F]F-CH PET/CT demonstrated superior accuracy in detecting pathological parathyroid glandscompared to [<sup>99m</sup>Tc]Tc-MIBI SPECT/CT and USG. [<sup>18</sup>F]F-CH PET/CT correctly identified 98.9% of patientswith pathological glands, with a specific location accuracy of 93.2%, 65.9% and 38.8% for [<sup>18</sup>F]F-CH PET/CT,[<sup>99m</sup>Tc]Tc-MIBI SPECT/CT and USG, respectively.</div><div>For ectopic adenomas, FCH PET/CT achieved an accuracy of 100% (4/4), while MIBI and neck ultrasound identified these in 50% (2/4) and 0% (0/4) of cases, respectively.</div><div>There were two cases of multiglandular disease, [<sup>18</sup>F]F-CH PET/CT and [99mTc]Tc-MIBI each detected one gland in one case (50%) while USG detected none; in the other case, [<sup>18</sup>F]F-CH PET/CT and USG identified both glands (100%), and [99mTc]Tc-MIBI detected none.</div><div>Significant correlations were observed between SUVmax values from [<sup>18</sup>F]F-CH PET/CT and gland size, weight, and preoperative PTH levels.</div></div><div><h3>Conclusions</h3><div>[<sup>18</sup>F]F-CH PET/CT outperformed conventional imaging modalities in the preoperative localization of HFPT, particularly in challenging cases such ectopic or multiglandular disease. These findings support its potential as an effective and reliable imaging tool for the management of primary hyperparathyroidism.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500091"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COMUNICACIONES ORALES (COMUNICACIONES ORALES) 口头来文
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-06-01 Epub Date: 2025-10-03 DOI: 10.1016/S2253-654X(25)00136-2
{"title":"COMUNICACIONES ORALES (COMUNICACIONES ORALES)","authors":"","doi":"10.1016/S2253-654X(25)00136-2","DOIUrl":"10.1016/S2253-654X(25)00136-2","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 ","pages":"Pages S1-S137"},"PeriodicalIF":1.6,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PÓSTERES (PÓSTERES) 海报(海报)
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-06-01 Epub Date: 2025-10-03 DOI: 10.1016/S2253-654X(25)00137-4
{"title":"PÓSTERES (PÓSTERES)","authors":"","doi":"10.1016/S2253-654X(25)00137-4","DOIUrl":"10.1016/S2253-654X(25)00137-4","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 ","pages":"Pages S1-S179"},"PeriodicalIF":1.6,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Malacoplaquia renal y pulmonar con afectación mediastínica que simula en estudio PET/TC con [18F]FDG una neoplasia sincrónica 在PET/TC研究中模拟[18F]FDG同步肿瘤的肾和肺恶性增生。
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-05-01 Epub Date: 2025-03-06 DOI: 10.1016/j.remn.2025.500124
J.R. Garcia, A. Compte, S. Romero, L. Mont, L. Pinilla, E. Riera
{"title":"Malacoplaquia renal y pulmonar con afectación mediastínica que simula en estudio PET/TC con [18F]FDG una neoplasia sincrónica","authors":"J.R. Garcia,&nbsp;A. Compte,&nbsp;S. Romero,&nbsp;L. Mont,&nbsp;L. Pinilla,&nbsp;E. Riera","doi":"10.1016/j.remn.2025.500124","DOIUrl":"10.1016/j.remn.2025.500124","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 3","pages":"Article 500124"},"PeriodicalIF":1.6,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143868721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista Espanola De Medicina Nuclear E Imagen Molecular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1